APA (7th ed.) Citation

Kakehashi, A., Suzuki, S., Nishidoi, Y., Hagihara, A., Ikenaga, H., Shiota, M., . . . Wanibuchi, H. (2025). The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma. Cancers, 17(13), 2212. https://doi.org/10.3390/cancers17132212

Chicago Style (17th ed.) Citation

Kakehashi, Anna, et al. "The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma." Cancers 17, no. 13 (2025): 2212. https://doi.org/10.3390/cancers17132212.

MLA (9th ed.) Citation

Kakehashi, Anna, et al. "The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma." Cancers, vol. 17, no. 13, 2025, p. 2212, https://doi.org/10.3390/cancers17132212.